Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
MYLK, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme.
Showing 10 out of 120 products:
Human Polyclonal MYLK Primary Antibody for IHC (p), WB - ABIN392494
Rossi, Ralay Ranaivo, Patel, Chrzaszcz, Venkatesan, Wainwright: Albumin causes increased myosin light chain kinase expression in astrocytes via p38 mitogen-activated protein kinase. in Journal of neuroscience research 2011
Show all 2 Pubmed References
Human Polyclonal MYLK Primary Antibody for IHC (p), WB - ABIN392495
Rossi, Todd, Daniels, Bazan, Belayev: Interferon Stimulated Gene 15 upregulation precedes the development of blood brain barrier disruption and cerebral edema after traumatic brain injury in young mice. in Journal of neurotrauma 2015
Show all 2 Pubmed References
Recombinant human MLCK was concentration- and time-dependently degraded by recombinant human MMP9 (show MMP9 Antibodies) in vitro, and this process was prevented by the MMP9 (show MMP9 Antibodies) inhibitor.
High expression of MLCK is correlated with metastatic triple negative breast cancer.
Interaction between kinase domain and regulatory light chain (RLC) substrate is identified in the absence of calmodulin, indicating restored substrate-binding capability due to mechanically induced removal of the auto-inhibitory regulatory region.
loss of MLCK contributes to the migratory properties of epithelial cells resulting from changes in cell-cell and cell-matrix adhesions, and increased epidermal growth factor receptor (show EGFR Antibodies) signaling.
Sixty-seven experienced runners competed in a marathon race. The MLCK genotype (C37885A) of these marathoners was determined. CA heterozygotes for MLCK C37885A might present higher exercise-induced muscle damage after a marathon competition than CC counterparts.
these Acute respiratory distress syndrome (ARDS)-associated MYLK cytosine-guanine dinucleotides with effect modification by ethnicity and local modified cytosine quantitative trait loci suggest that MYLK epigenetic variation and local genetic background may contribute to health disparities observed in ARDS.
mechanical stress and MYLK single nucleotide polymorphism regulate MYLK alternative splicing.
Rebeccamycin attenuates TNF-alpha (show TNF Antibodies)-induced disruption of intestinal epithelial barrier integrity by inducing claudin-5 (show CLDN5 Antibodies) expression and suppressing MLCK production via Chk1 (show CHEK1 Antibodies) activation.
Data show that alterations in myosin light chain kinase activity, claudin-15 (show CLDN15 Antibodies) and claudin-2 (show CLDN2 Antibodies) expression are associated with gluten-induced symptomatology and intestinal permeability changes in diarrhea-predominant irritable bowel syndrome (IBS-D).
PXR (show NR1I2 Antibodies) regulates the intestinal epithelial barrier during inflammation by modulating cytokine-induced MLCK expression and JNK1 (show MAPK8 Antibodies)/2 activation
Histamine induces myosin light chain (MLC)phosphorylation via MYLK, suggesting regulatory role for MLC in controlling corneal epithelial permeability.
evaluated the spatial arrangement of the catalytic/regulatory domain, three immunoglobulin-related motifs, one fibronectin-related motif, a repetitive, proline-rich segment, and, at the N-terminus, a unique F-actin-binding domain.
telokin may play a role in attenuating constitutive myosin light chain phosphorylation
MLCK is linked to timely blastocyst formation, though it is dispensable for oocyte meiotic maturation
NF-kappaB (show NFKB1 Antibodies) novel partner within endothelial cells
MLCK regulates cell migration in a myosin regulatory light chain phosphorylation-independent mechanism.
nmMlck modulates IL-1beta (show IL1B Antibodies)-mediated downregulation of Cldn5 (show CLDN5 Antibodies) in brain microvascular endothelial cells.
a prominent effect of the multifunctional microRNA-155 in endothelial cells is modulation of phenotype through alterations in RhoA, myosin light chain kinase expression, and actin cytoskeleton organization
CArG element in intron 15 of the mylk1 gene is necessary for maximal expression of the 130-kDa smMLCK and that the 130-kDa smMLCK isoform is specifically required to regulate smooth muscle contractility
In immune-mediated inflammatory bowel disease, tight junction dysregulation and barrier loss is induced by MLCK, but at advanced stages, barrier loss is MLCK-independent.
Claudin-2 (show CLDN2 Antibodies) assumes an important role in colorectal inflammation, and furthermore implicates the involvement of MLCK in colon inflammation.
involved in IL-1beta (show IL1B Antibodies)-induced increase in intestinal permeability
This gene, a muscle member of the immunoglobulin gene superfamily, encodes myosin light chain kinase which is a calcium/calmodulin dependent enzyme. This kinase phosphorylates myosin regulatory light chains to facilitate myosin interaction with actin filaments to produce contractile activity. This gene encodes both smooth muscle and nonmuscle isoforms. In addition, using a separate promoter in an intron in the 3' region, it encodes telokin, a small protein identical in sequence to the C-terminus of myosin light chain kinase, that is independently expressed in smooth muscle and functions to stabilize unphosphorylated myosin filaments. A pseudogene is located on the p arm of chromosome 3. Four transcript variants that produce four isoforms of the calcium/calmodulin dependent enzyme have been identified as well as two transcripts that produce two isoforms of telokin. Additional variants have been identified but lack full length transcripts.
kinase related protein, telokin
, myosin, light chain kinase
, myosin light chain kinase
, myosin light chain kinase, smooth muscle-like
, kinase-related protein
, myosin light chain kinase, smooth muscle
, myosin, light polypeptide kinase
, smooth muscle myosin light chain kinase
, smooth muscle myosin light chain kinase (61-kDa active fragment)